{"@type":"Dataset","go_id":["https://identifiers.org/GO:0005737","https://identifiers.org/GO:0007155"],"go_kw":["cytoplasm","cell adhesion"],"integmet_study":"MTBLS6402","mesh_disease_id":["https://identifiers.org/mesh:D000306","https://identifiers.org/mesh:D018268","https://identifiers.org/mesh:D009362","https://identifiers.org/mesh:D004700"],"mesh_disease_pubtator_kw":["ACC cancer","ACC","adrenocortical carcinoma","metastases","endocrine malignancy","Adrenocortical carcinoma"],"mesh_gene_id":["https://identifiers.org/ncbigene:6624","https://identifiers.org/ncbigene:207","https://identifiers.org/ncbigene:2516","https://identifiers.org/ncbigene:7410","https://identifiers.org/ncbigene:1499"],"mesh_gene_pubtator_kw":["FSCN1","fascin","Rac","SF-1","VAV2","Steroidogenic Factor-1","beta-catenin"],"ncbi_taxonomy_id":["https://identifiers.org/taxonomy:7955","https://identifiers.org/taxonomy:9606"],"ncbi_taxonomy_pubtator_kw":["zebrafish","patients"],"source_id":"https://identifiers.org/metabolights:MTBLS6402","study_findings":"FSCN1 inactivation reduces ACC cell invasion and metastasis.","study_observation":"Effects of FSCN1 inactivation on ACC cell invasion.","study_summary":"FSCN1 as a target in ACC treatment.","study_title_original":"FSCN1 as a new druggable target in adrenocortical carcinoma"}